KRRO
Korro Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.16
+4.65%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 171.90x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.73x
- Price / sales
- 75.17x
- Price / cash flow
- -2.64x
Enterprise value
- Enterprise value
- $106.2M
- EV / sales
- 44.60x
- EV / EBITDA
- -1.48x
- EV / EBIT
- -1.40x
- Market cap
- $179.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026